TCTMD: ADHD drug overprescribing raises concerns over future CV events

August 12, 2020

Research shows that prescription stimulants used to treat attention-deficit/hyperactivity disorder (ADHD) raise blood pressure and resting heart rate, but the long-term cardiovascular risks of using them is unclear.

TCTMD talked to  Dr. James O'Keefe, a preventative cardiologist at Saint Luke's Mid America Heart Institute, about his recent review paper on the need for clarification on the potential dangers of stimulant use in children and adults.

"It's a public health message that I think is overdue," said Dr. O'Keefe. "We need to track this closely and we need to be really careful about doses, about who's getting it, about how long they're taking it."

Read the full tctMD article: ADHD drug overprescribing raises concerns over future CV events

Related Content

Saint Luke’s recognized on U.S. News and World Report’s 2020-21 Best Hospitals List
Saint Luke’s Hospital of Kansas City ranks No. 2 in Missouri, No. 2 in the Kansas City metro area, and is recognized among the Best Hospitals in northwestern Missouri.
ABC News: FDA approves drug for heart failure that may keep patients out of the hospital during the COVID-19 pandemic
Farxiga has become the first in its class to receive FDA approval as a treatment for heart failure. ABC News talked to Dr. Mikhail Kosiborod about what this means for patients.
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
KMBC: Worldwide clinical drug trial for COVID-19 led by a doctor at Saint Luke's
As the entire world comes together to attempt to find a vaccine and treatments for this global pandemic, it is exciting that an international trial of this nature was created and is being led by doctors and researchers here in Kansas City.